stockportfolio.pro
Privia Health Group, Inc. P/E Ratio 2019–2025
Privia Health Group, Inc. (PRVA) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +1.4%/yr over 6 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 131.72 | -25.9% |
| FY 2024 | 177.73 | +46.6% |
| FY 2023 | 121.21 | — |
| FY 2022 | — | — |
| FY 2021 | — | — |
| FY 2020 | — | — |
| FY 2019 | — | — |
Source: Privia Health Group, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Privia Health Group, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePrivia Health Group, Inc. — frequently asked questions
What is Privia Health Group, Inc.'s price-to-earnings ratio?
Privia Health Group, Inc. (PRVA) reported price-to-earnings ratio of 131.72 for fiscal year 2025, per its SEC filings.
How has Privia Health Group, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2019 and 2025, PRVA's price-to-earnings ratio grew at roughly 1.4% per year (compound annual rate), from 121.21 to 131.72.
Where does this data come from?
Figures are computed from Privia Health Group, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.